Human Dental Pulp Stem Cells (hDPSC)

Unit

3 x 10^6 cells/ml

Cell Type

Primary Cells

Tissue Type

Oral cells

,

Primary Cells

Organism

Human

Donor History
Growth Properties

Adherent

Growth Conditions

Culture medium: Alpha MEM

,

w: 2.0 mM stable Glutamine

,

w/o: Ribonucleosides

,

w/o: Deoxyribonucleosides

,

w: 1.0 mM Sodium pyruvate

,

w: 2.2g/L NaHCO3. Supplements: Supplement the medium with 10% FBS

,

2 ng/mL bFGF. Dissociation reagent: Accutase. Freeze medium: As a cryopreservation medium

,

we use 90% FBS + 10% DMSO to maintain viability

,

or CM-1 (Cytion catalog number 800100)

,

which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C

,

5% CO2

,

humidified atmosphere.

Immortalization Method
Full Information

https://www.cytion.com/Human-Dental-Pulp-Stem-Cells-hDPSC/300702

SKU: 300702 Kategorie: ,
Mgr. Otakar Fišer
Máte otázky k tomuto produktu? Kontaktujte našeho specialistu.
Mgr. Otakar Fišer
Produktový manažer - Life Science
Popis

Human Dental Pulp Stem Cells (DPSC, hDPSC) are multipotent stem cells isolated from the dental pulp of adult teeth, commonly third molars. These cells are particularly valuable in regenerative medicine due to their ability to differentiate into a variety of cell types, including those that form bone, cartilage, fat, and dental tissues. DPSCs are noted for their high proliferative capacity, making them a robust choice for tissue engineering and cell-based therapeutic applications.

DPSCs also possess significant immunomodulatory properties, which contribute to their potential use in treating inflammatory conditions. Beyond dental tissue regeneration, they have been investigated for their ability to repair bone defects and for their application in neurological therapies. Their relatively easy accessibility and the ability to maintain viability after cryopreservation make DPSCs an attractive option for clinical research and therapeutic development, particularly in the areas of regenerative dentistry, orthopedics, and neurodegenerative diseases.

O značce

Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.

Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.